HQH

abrdn Healthcare Investors (HQH) operates as a closed-end investment fund specializing in healthcare and biotechnology securities. Managed by abrdn Inc., the fund invests primarily in equity and debt securities of companies across the healthcare sector, including pharmaceuticals, biotechnology, medical devices, healthcare services, and healthcare technology. The fund employs a leveraged investment strategy to enhance returns, utilizing borrowings to amplify its investment positions in both domestic and international healthcare markets. HQH maintains a diversified portfolio that spans early-stage biotechnology firms developing novel therapeutics to established pharmaceutical companies and medical device manufacturers. The fund focuses on identifying investment opportunities across the entire healthcare value chain, from research and development through commercialization and distribution. As a closed-end fund, HQH trades on the New York Stock Exchange and offers investors exposure to a professionally managed portfolio of healthcare investments with the potential for both capital appreciation and income generation through dividends. The fund's management team leverages abrdn's global research capabilities and healthcare sector expertise to identify compelling investment opportunities. HQH's portfolio composition reflects current healthcare industry trends, including precision medicine, digital health solutions, and innovative medical technologies. The fund provides regular distributions to shareholders and maintains active portfolio management to adapt to evolving market conditions and regulatory environments within the dynamic healthcare sector.